Abstract
Anticoagulation plays a major role in reducing the risk of systematic thrombosis in patients with severe COVID-19. Serious hemorrhagic complications, such as intracranial hemorrhage, have also been recognized. However, intra-abdominal hemorrhage is under-recognized because of its rare occurrence, despite high mortality. Here, we discuss two cases of spontaneous iliopsoas hematoma (IPH) likely caused by anticoagulants during the clinical course of COVID-19. We also explored published case reports to identify clinical characteristics of IPH in COVID-19 patients. The use of anticoagulants may increase the risk of lethal IPH among COVID-19 patients becsuse of scarce data on optimal dosage and adequate monitoring of anticoagulant effects. Rapid diagnosis and timely intervention are crucial to ensure good patient outcomes.
【초록키워드】 COVID-19, anticoagulation, thrombosis, severe COVID-19, Clinical characteristics, Diagnosis, risk, Intervention, Case report, outcomes, Clinical course, Patient, Rapid, complications, COVID-19 patients, Anticoagulants, Anticoagulant, COVID-19 patient, hemorrhage, hematoma, intracranial hemorrhage, anticoagulant effects, Hemorrhagic, dosage, high mortality, Occurrence, identify, caused, reducing, 【제목키워드】 COVID-19, clinical, Iliopsoa,